These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 11910583)

  • 21. Risk of hand osteoarthritis in new users of hormone replacement therapy: A nested case-control analysis.
    Burkard T; Rauch M; Spoendlin J; Prieto-Alhambra D; Jick SS; Meier CR
    Maturitas; 2020 Feb; 132():17-23. PubMed ID: 31883658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Life prevalence and determinants of hormone replacement therapy in women living in Porto, Portugal.
    Lucas R; Barros H
    Maturitas; 2007 Jul; 57(3):226-32. PubMed ID: 17293067
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hormone replacement therapy. Knowledge, attitudes and practices of women attending a gynaecology outpatient clinic in Trinidad.
    Akong J; Hoon KN; Dial C; Andrewin A; Diaz M; Charles J; Sandiford N; Ward C; McDougall L; Teelucksingh S
    West Indian Med J; 2001 Jun; 50(2):155-8. PubMed ID: 11677916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hormone replacement therapy use and plasma levels of sex hormones in the Norwegian Women and Cancer postgenome cohort - a cross-sectional analysis.
    Waaseth M; Bakken K; Dumeaux V; Olsen KS; Rylander C; Figenschau Y; Lund E
    BMC Womens Health; 2008 Jan; 8():1. PubMed ID: 18194511
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of hormone replacement therapy by postmenopausal women after publication of the Women's Health Initiative Trial.
    Ness J; Aronow WS; Newkirk E; McDanel D
    J Gerontol A Biol Sci Med Sci; 2005 Apr; 60(4):460-2. PubMed ID: 15933383
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The relationship of race/ethnicity and social class to hormone replacement therapy: results from the Third National Health and Nutrition Examination Survey 1988-1994.
    Friedman-Koss D; Crespo CJ; Bellantoni MF; Andersen RE
    Menopause; 2002; 9(4):264-72. PubMed ID: 12082362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for genital prolapse in non-hysterectomized women around menopause. Results from a large cross-sectional study in menopausal clinics in Italy. Progetto Menopausa Italia Study Group.
    Eur J Obstet Gynecol Reprod Biol; 2000 Dec; 93(2):135-40. PubMed ID: 11074133
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age and menopausal effects of hormonal birth control and hormone replacement therapy in relation to breast cancer risk.
    Shantakumar S; Terry MB; Paykin A; Teitelbaum SL; Britton JA; Moorman PG; Kritchevsky SB; Neugut AI; Gammon MD
    Am J Epidemiol; 2007 May; 165(10):1187-98. PubMed ID: 17337757
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of hormone replacement therapy in Italian women aged 50-70 years.
    Manzoli L; Di Giovanni P; Del Duca L; De Aloysio D; Festi D; Capodicasa S; Monastra G; Romano F; Staniscia T
    Maturitas; 2004 Nov; 49(3):241-51. PubMed ID: 15488353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Are long-term hormone replacement therapy users different from short-term and never users?
    Buist DS; LaCroix AZ; Newton KM; Keenan NL
    Am J Epidemiol; 1999 Feb; 149(3):275-81. PubMed ID: 9927224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determinants of age at menopause in women attending menopause clinics in Italy.
    Parazzini F;
    Maturitas; 2007 Mar; 56(3):280-7. PubMed ID: 17069999
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of the QoL in Italian menopausal women: comparison between HRT users and non-users.
    Genazzani AR; Nicolucci A; Campagnoli C; Crosignani P; Nappi C; Serra GB; Bottiglioni E; Cianci A; De Aloysio D; Donati Sarti C; Gambacciani M; Monteleone P; Genazzani AD; Guaschino S; Palumbo G; Petraglia F; Schonauer S; Volpe A; Di Paolantonio T; Nagni M; Tempesta A; Coronel GA;
    Maturitas; 2002 Aug; 42(4):267-80. PubMed ID: 12191849
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of hormone replacement therapy: women's representations of menopause and beauty care practices.
    Fauconnier A; Ringa V; Delanoë D; Falissard B; Bréart G
    Maturitas; 2000 Jun; 35(3):215-28. PubMed ID: 10936738
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Premature ovarian failure: frequency and risk factors among women attending a network of menopause clinics in Italy.
    Progetto Menopausa Italia Study Group
    BJOG; 2003 Jan; 110(1):59-63. PubMed ID: 12504937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. What factors account for hormone replacement therapy prescribing frequency?
    Newton KM; LaCroix AZ; Buist DS; Anderson LA; Delaney K
    Maturitas; 2001 Jul; 39(1):1-10. PubMed ID: 11451615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The association of asthma, atopy and lung function with hormone replacement therapy and surgical cessation of menstruation in a population-based sample of English women.
    Jarvis D; Leynaert B
    Allergy; 2008 Jan; 63(1):95-102. PubMed ID: 17970824
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physician specialty is significantly associated with hormone replacement therapy use.
    Levy BT; Ritchie JM; Smith E; Gray T; Zhang W
    Obstet Gynecol; 2003 Jan; 101(1):114-22. PubMed ID: 12517655
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of hormone replacement therapy among Chilean women: a comparison between socioeconomic levels.
    Blümel JE; Castelo-Branco C; Riquelme R; Araya H; Jaramillo P; Tacla X; Colodrón M; Lavín P
    Menopause; 2002; 9(5):377-80. PubMed ID: 12218727
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hysteroscopic findings in postmenopausal abnormal uterine bleeding: a comparison between HRT users and non-users.
    Perrone G; DeAngelis C; Critelli C; Capri O; Galoppi P; Santoro G; Nofroni I; Zichella L
    Maturitas; 2002 Dec; 43(4):251-5. PubMed ID: 12468133
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The association of age at menopause and all-cause and cause-specific mortality by race, postmenopausal hormone use, and smoking status.
    Malek AM; Vladutiu CJ; Meyer ML; Cushman M; Newman R; Lisabeth LD; Kleindorfer D; Lakkur S; Howard VJ
    Prev Med Rep; 2019 Sep; 15():100955. PubMed ID: 31367516
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.